NK cells in HIV infection: paradigm for protection or targets for ambush.
about
The CD85j+ NK cell subset potently controls HIV-1 replication in autologous dendritic cellsSlow turnover of HIV-1 receptors on quiescent CD4+ T cells causes prolonged surface retention of gp120 immune complexes in vivoCoinfection with Hepatitis C Virus and Human Immunodeficiency Virus: Virological, Immunological, and Clinical OutcomesEnrichment of variations in KIR3DL1/S1 and KIR2DL2/L3 among H1N1/09 ICU patients: an exploratory studyHepatic stellate cells: protean, multifunctional, and enigmatic cells of the liverAntibody-Mediated Fcγ Receptor-Based Mechanisms of HIV Inhibition: Recent Findings and New Vaccination StrategiesDeficient major histocompatibility complex-linked innate murine cytomegalovirus immunity in MA/My.L-H2b mice and viral downregulation of H-2k class I proteins.Lysis of endogenously infected CD4+ T cell blasts by rIL-2 activated autologous natural killer cells from HIV-infected viremic individuals.Impact of HIV on cell survival and antiviral activity of plasmacytoid dendritic cellsNef, macrophages and B cells: a highway for evasionDendritic cells/natural killer cross-talk: a novel target for human immunodeficiency virus type-1 protease inhibitors.Decreased NK cell frequency and function is associated with increased risk of KIR3DL allele polymorphism in simian immunodeficiency virus-infected rhesus macaques with high viral loads.CD8+ lymphocytes control viral replication in SIVmac239-infected rhesus macaques without decreasing the lifespan of productively infected cells.Impaired natural killer cell responses are associated with loss of the highly activated NKG2A(+)CD57(+)CD56(dim) subset in HIV-1 subtype D infection in Uganda.Defective plasmacytoid dendritic cell-NK cell cross-talk in HIV infection.Similar impact of CD8+ T cell responses on early virus dynamics during SIV infections of rhesus macaques and sooty mangabeys.Cutting Edge: Unusual NK cell responses to HIV-1 peptides are associated with protection against maternal-infant transmission of HIV-1.Selective serotonin reuptake inhibitor and substance P antagonist enhancement of natural killer cell innate immunity in human immunodeficiency virus/acquired immunodeficiency syndromeIL-21-mediated reversal of NK cell exhaustion facilitates anti-tumour immunity in MHC class I-deficient tumoursNK cell responses to simian immunodeficiency virus vaginal exposure in naive and vaccinated rhesus macaquesPersistent virus infection inhibits type I interferon production by plasmacytoid dendritic cells to facilitate opportunistic infections.HIV-1 Vpu antagonism of tetherin inhibits antibody-dependent cellular cytotoxic responses by natural killer cells.Natural killer cell function and dysfunction in hepatitis C virus infection.Immune dysregulation in human immunodeficiency virus infection: know it, fix it, prevent it?Accessory cell dependent NK cell mediated PBMC IFN-gamma production is defective in HIV infection.In vitro naïve T cell proliferation failure predicts poor post-immunization responses to neoantigen, but not recall antigens, in HIV-infection.Selective serotonin reuptake inhibitor suppression of HIV infectivity and replication.Loss of CCR7 expression on CD56(bright) NK cells is associated with a CD56(dim)CD16⁺ NK cell-like phenotype and correlates with HIV viral load.Naïve rat NK cells control the onset of T cell responseRapid expansion and long-term persistence of elevated NK cell numbers in humans infected with hantavirus.High frequencies of polyfunctional CD8+ NK cells in chronic HIV-1 infection are associated with slower disease progressionNK cells and CD1d-restricted NKT cells respond in different ways with divergent kinetics to IL-2 treatment in primary HIV-1 infectionNatural killer cells that respond to human immunodeficiency virus type 1 (HIV‐1) peptides are associated with control of HIV‐1 infectionNK cells and their ability to modulate T cells during virus infectionsHuman immunodeficiency virus type 1 infection is associated with increased NK cell polyfunctionality and higher levels of KIR3DL1+ NK cells in ugandans carrying the HLA-B Bw4 motif.Antibody-dependent cell-mediated cytotoxicity in simian immunodeficiency virus-infected rhesus monkeysLevels of CD56+TIM-3- effector CD8 T cells distinguish HIV natural virus suppressors from patients receiving antiretroviral therapy.Activation of NK cells by ADCC antibodies and HIV disease progression.Persistence of pathological distribution of NK cells in HIV-infected patients with prolonged use of HAART and a sustained immune responseNatural killer cell activation enhances immune pathology and promotes chronic infection by limiting CD8+ T-cell immunity
P2860
Q21144323-53EE3A21-95F3-44F7-ACE4-03AB5165971CQ27330487-5EB90877-AFB8-46A6-86E2-8C08F8A2C69CQ27488883-CE1DC087-D1A2-4083-94A8-E21CF1404B9EQ28740790-EBA869D1-D70A-434F-95F3-CDE6D6FE6059Q29616840-C1213BBF-2028-420C-A998-5E0242D59D5FQ30408097-CD8B2F05-5DA1-4E02-8325-8EFA09AA7024Q30441926-E4E7E543-E16F-4DC6-860C-E4B6BB6A7EFFQ30845033-768E19BA-EBE0-48BA-8928-6A8A64B6A6F7Q33285471-C21AF098-6DCB-4C60-BB25-D018F955A484Q33584327-9D02CE70-402E-42E9-B484-53DB8D5525ADQ33604765-C850F7A5-FF2E-4DF0-80AD-98D594A07EDFQ33609877-04A76977-D1EF-44C1-968B-4F657D322903Q33618007-F1175515-CD3B-48DF-AD21-35B867E28675Q33654658-147BC2E6-7811-4B38-A933-1EC02FFE6475Q33686528-DD7C3056-D8C7-4D18-9336-09D57DB78805Q33701593-5993F951-9091-41BD-87AA-E22D31C2FF96Q33739243-3BE3D659-7620-406E-B602-10A9B64E9377Q33752757-362E38BD-2283-4194-8B76-F3AD8680A68BQ33786422-C48BF6E9-5A4E-44F8-B829-D83325B3678CQ33851763-F61027B2-7D82-46C5-8FB0-E6FA06B8022AQ33874809-0C708247-9DB4-4000-9F06-69E5D3069F5FQ33887674-4B365528-029E-43D9-B988-5CABF959FD47Q33892695-A42C1C33-E3B5-4AB8-A579-EA430C32DF02Q33992829-C0C6CBA9-DD03-45B5-AA06-AE3117BE5688Q34020126-DAF273DC-24FC-4B3C-9B80-4B4B80FC3028Q34050143-0889F6E4-823D-4239-96B6-3D403D79E3C8Q34297847-9EF1FF1D-19ED-4F9F-B425-1460BD140BC8Q34427488-906E67D3-7FA3-493C-9D6B-90AE842EFA07Q34450539-AD0715E0-F784-4E80-A871-134612586641Q34501427-06F0C10C-DD27-4352-AA28-4EDDE68723D3Q34593740-DBC719DE-EF69-47D6-8488-08E44709B8BCQ34680046-DD263C3E-7358-4291-A48D-F380347D5602Q34694776-F5D2DBE3-B84D-4568-9F32-2656AF618FA2Q34700499-2A732E75-87AD-44A9-9942-511C7D085DCFQ35076703-0932BF20-CB0A-4140-A205-9F6CC3759958Q35077793-B6AD40A2-7A6A-4E06-8DEC-D5ACC29D8251Q35092923-A9DAECC7-FB87-44C8-B855-15D4E137C655Q35218850-852FD412-EB69-4795-A778-826AD06B8C57Q35219896-BD020E72-022F-444A-8BD7-461E3E4069FAQ35709263-261F7BF2-4E87-4C97-9746-B3BEA9502148
P2860
NK cells in HIV infection: paradigm for protection or targets for ambush.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
NK cells in HIV infection: paradigm for protection or targets for ambush.
@ast
NK cells in HIV infection: paradigm for protection or targets for ambush.
@en
type
label
NK cells in HIV infection: paradigm for protection or targets for ambush.
@ast
NK cells in HIV infection: paradigm for protection or targets for ambush.
@en
prefLabel
NK cells in HIV infection: paradigm for protection or targets for ambush.
@ast
NK cells in HIV infection: paradigm for protection or targets for ambush.
@en
P50
P356
P1476
NK cells in HIV infection: paradigm for protection or targets for ambush.
@en
P304
P356
10.1038/NRI1711
P577
2005-11-01T00:00:00Z